...
首页> 外文期刊>International Journal of Molecular Sciences >Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
【24h】

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity

机译:乙酰胆碱酯酶和丁酰胆碱酯酶的抑制剂具有免疫性

获取原文
           

摘要

Acetylcholinesterase (AChE) inhibitors are widely used for the symptomatic treatment of Alzheimer’s disease and other dementias. More recent use is for myasthenia gravis. Many of these inhibitors interact with the second known cholinesterase, butyrylcholinesterase (BChE). Further, evidence shows that acetylcholine plays a role in suppression of cytokine release through a “cholinergic anti-inflammatory pathway” which raises questions about the role of these inhibitors in the immune system. This review covers research and discussion of the role of the inhibitors in modulating the immune response using as examples the commonly available drugs, donepezil, galantamine, huperzine, neostigmine and pyridostigmine. Major attention is given to the cholinergic anti-inflammatory pathway, a well-described link between the central nervous system and terminal effector cells in the immune system.
机译:乙酰胆碱酯酶(AChE)抑制剂被广泛用于对症治疗阿尔茨海默氏病和其他痴呆症。最近用于重症肌无力。这些抑制剂中有许多与第二种已知的胆碱酯酶,丁酰胆碱酯酶(BChE)相互作用。此外,有证据表明,乙酰胆碱通过“胆碱能抗炎途径”在抑制细胞因子释放中起作用,这引发了有关这些抑制剂在免疫系统中的作用的疑问。本文以常用药物多奈哌齐,加兰他敏,石杉碱,新斯的明和吡啶斯的明为例,对抑制剂在调节免疫应答中的作用进行了研究和讨论。主要关注胆碱能抗炎途径,这是中枢神经系统与免疫系统终末效应细胞之间的良好联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号